FDA addresses COVID vaccine concerns in news briefing: What to know
In a rare weekend press conference, the U.S. Food and Drug Administration (FDA) — who is responsible for authorizing widespread use of Pfizer’s coronavirus vaccine on Friday — discussed some of people’s biggest concerns about the vaccine.
Following a rapid development and review process, many people still have questions about who is safe to receive the COVID-19 vaccine. Touching on topics of allergic reactions, age and pregnant and breastfeeding women, FDA officials say they are confident in the safety of the vaccine, but encourage some individuals to consult with their physician before receiving the shots.
New today: Michigan coronavirus cases up to 430,780; Death toll now at 10,662
Metro Detroit weather: Going from mild to chilly, Saturday evening
After highs in the 50s, temperatures plummet through Saturday night. It will be mostly cloudy and colder, with overnight lows in the low 30s.
4 Fast Facts